HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wang, H. Articles by Wollheim, C. B. Search for Related Content PubMed PubMed Citation Articles by Wang, H. Articles by Wollheim, C. B. Social Bookmarking                What's this?

Experimental Models of Transcription Factor-Associated Maturity-Onset Diabetes of the Young

¹ Department of Internal Medicine, Division of Clinical Biochemistry, University Medical Centre, Geneva, Switzerland
² Biochemistry Institute, University of Lausanne, Lausanne, Switzerland
³ Department of Morphology, University Medical Centre, Geneva, Switzerland

Six monogenic forms of maturity-onset diabetes of the young (MODY) have been identified to date. Except for MODY2 (glucokinase), all other MODY subtypes have been linked to transcription factors. We have established a MODY3 transgenic model through the ß-cell–targeted expression of dominant-negative HNF-1 either constitutively (rat insulin II promoter) or conditionally (Tet-On system). The animals display either overt diabetes or glucose intolerance. Decreased insulin secretion and reduced pancreatic insulin content contribute to the hyperglycemic state. The conditional approach in INS-1 cells helped to define new molecular targets of hepatocyte nuclear factor (HNF)-1. In the cellular system, nutrient-induced insulin secretion was abolished because of impaired glucose metabolism. Conditional suppression of HNF-4, the MODY1 gene, showed a similar phenotype in INS-1 cells to HNF-1. The existence of a regulatory circuit between HNF-4 and HNF-1 is confirmed in these cell models. The MODY4 gene, IPF-1 (insulin promoter factor-1)/PDX-1 (pancreas duodenum homeobox-1), controls not only the transcription of insulin but also expression of enzymes involved in its processing. Suppression of Pdx-1 function in INS-1 cells does not alter glucose metabolism but rather inhibits insulin release by impairing steps distal to the generation of mitochondrial coupling factors. The presented experimental models are important tools for the elucidation of the ß-cell pathogenesis in MODY syndromes.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				B. Desvergne, L. Michalik, and W. Wahli Transcriptional Regulation of Metabolism Physiol Rev, April 1, 2006; 86(2): 465 - 514. [Abstract] [Full Text] [PDF]

				K. E Garnett, P. Chapman, J. A Chambers, I. D Waddell, and D. S W Boam Differential gene expression between Zucker Fatty rats and Zucker Diabetic Fatty rats: a potential role for the immediate-early gene Egr-1 in regulation of beta cell proliferation J. Mol. Endocrinol., August 1, 2005; 35(1): 13 - 25. [Abstract] [Full Text] [PDF]

				M. S. Winzell, G. Pacini, C. B. Wollheim, and B. Ahren Beta-Cell-Targeted Expression of a Dominant-Negative Mutant of Hepatocyte Nuclear Factor-1{alpha} in Mice: Diabetes Model with {beta}-Cell Dysfunction Partially Rescued by Nonglucose Secretagogues Diabetes, December 1, 2004; 53(suppl_3): S92 - S96. [Abstract] [Full Text] [PDF]

				J. Eeckhoute, P. Formstecher, and B. Laine Hepatocyte Nuclear Factor 4{alpha} enhances the Hepatocyte Nuclear Factor 1{alpha}-mediated activation of transcription Nucleic Acids Res., May 11, 2004; 32(8): 2586 - 2593. [Abstract] [Full Text] [PDF]

				F. Ashcroft and P. Rorsman Type 2 diabetes mellitus: not quite exciting enough? Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R21 - R31. [Abstract] [Full Text] [PDF]